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Abstract
Kinases play key roles in cell signaling and represent major targets for drug development, but the regulation of their
activation and their associations with health and disease have not been systematically analyzed. Here, we carried out a
bioinformatic analysis of the expression levels of 459 human kinase genes in 5681 samples consisting of 44 healthy and 55
malignant human tissues. Defining the tissues where the kinase genes were transcriptionally active led to a functional
genomic taxonomy of the kinome and a classification of human tissues and disease types based on the similarity of their
kinome gene expression. The co-expression network around each of the kinase genes was defined in order to determine the
functional context, i.e. the biological processes that were active in the cells and tissues where the kinase gene was
expressed. Strong associations for individual kinases were found for mitosis (69 genes, including AURKA and BUB1), cell cycle
control (73 genes, including PLK1 and AURKB), DNA repair (49 genes, including CHEK1 and ATR), immune response (72 genes,
including MATK), neuronal (131 genes, including PRKCE) and muscular (72 genes, including MYLK2) functions. We then
analyzed which kinase genes gain or lose transcriptional activity in the development of prostate and lung cancers and
elucidated the functional associations of individual cancer associated kinase genes. In summary, we report here a systematic
classification of kinases based on the bioinformatic analysis of their expression in human tissues and diseases, as well as
grouping of tissues and tumor types according to the similarity of their kinome transcription.
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Introduction
Much of our knowledge on the functions of genes, both in health
and disease, is derived from molecular biological experiments with
specific model systems, which often provide a biased and context-
specific view of gene functions. In in vivo in human tissues, gene
function often varies from one organ to another as well as across
different disease states. The 518 human kinases represent an
intensively studied class of proteins which may regulate the activity of
up to a third of all human proteins by phosphorylation [1]. Because
of their central role in cell signalling, kinases are important targets for
drug development, particularly in cancer [2,3,4,5]. The role of
kinase genes in cancer has been systematically studied at the genomic
DNA level. For example, a recent cancer gene census [6] lists 33
kinases that may undergo genetic alterations in cancer. Numerous
reports have also been published on the differential expression of
kinase genes and proteins in specific types of cancers, but these results
are highly biased towards the most commonly studied kinase genes
and towards common cancer forms. Furthermore, published data
are often contradictory, precluding an assessment of the overall
importance of kinases across different diseases. Kinase genes are
known to be strongly regulated at the protein level, but
transcriptional level regulation has not been comprehensively
studied.
Meta-analyses of large publicly available microarray data
sources, such as GeneExpressionOmnibus [7] and ArrayExpress
[8] have been shown to facilitate the analysis gene expression
across healthy and disease states [9,10,11]. However, due to the
variability of microarray platforms from one study to another,
most investigators have analyzed each of the multiple datasets
separately [12,13,14,15,16,17], focusing on e.g. cancer-normal
comparisons within a tissue type. We reasoned that a direct
systematic comparison of kinase gene expression levels across all
cells, tissues and disease states would be more informative. We
have previously developed and reported a methodology for
integrating very large quantities of human expression data into a
unified format in order to create a comprehensive reference
database of the human transcriptome, GeneSapiens [18]. Here,
we made use of this methodology in order to perform the first
systematic study of kinase gene expression levels and co-expression
networks across thousands of healthy and malignant tissues.
Results
Definition of the transcriptional activity of kinase genes
The analysis focused on 459 genes encoding proteins with
protein kinase activity (Table S1) for which sufficient expression
data were available in the GeneSapiens database [18]. Expression
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e15068
levels of kinases were first analyzed across 55 major tumor types
(n = 4078 samples) and 44 healthy tissues (n = 1603 samples)
(Table S2). Expression of kinase genes across these 99 tissue types
was first analyzed in a binary fashion, defining those tissues and
tumor types where each kinase gene was transcriptionally active.
Previously such binary level analysis has been shown to be a useful
method to reduce noise [19,20]. A kinase gene was defined to be
transcriptionally active in a tissue if its median expression in the
tissue was more than the predefined background expression level
(Figure S1) across all healthy tissue types. We defined the
background gene expression activity for each kinase across the
1603 samples representing the healthy human transcriptome (see
methods section and Figure S1). Any kinase gene whose expression
levels in healthy or tumor tissues exceeding this range were
nominated as ‘‘transcriptionally active’’ (Figure 1, Figure S3) in the
corresponding tissues. Thus, from this analysis we were able to
define which tissue and tumor types most likely systematically
expressed each kinase gene at an active level in majority of the
samples of the tissue type and thus potentially contributing to the
biological functions active in that tissue.
Clustering of the binarized expression levels of kinase genes
along both the gene and tissue dimensions revealed distinct
transcriptionally active kinome profiles and a classification of tissue
types based on such activity profiles (Figure 1A–B). For example,
kinome gene expression activity levels distinguished a group of
‘‘Healthy’’ tissues, of which 92.6% were normal tissues, with
distinct subgroups of neuronal and muscular tissues. The group
‘‘Immunological and hematological’’ was almost entirely com-
posed of (94.7%) immunological and hematological tissues. The
‘‘Solid cancer’’ group consisted of 94.7% of solid tumor samples,
with subgroups of non-epithelial and epithelial cancers. Epithelial
tumors could also be further divided into squamous and
adenocarcinomas. Additionally, one mixed group was formed
(50% healthy and 50% cancer).
Conversely, several groups of kinases having distinct transcrip-
tional activity patterns across various tissue groups were identified
(Figure 1A, Table 1). For example, one of the most prominent ones
was mainly active in solid cancers and immunological/hematolog-
ical tissues. Kinase genes belonging to this group were transcrip-
tionally active in 88.7% of solid cancers and in 65.8% of
immunological/hematological tissues. In the healthy and mixed
tissue groups the percentages were 20.8% and 44.2%, respectively.
This group of kinases was named ‘‘proliferation’’ kinase genes.
Similarly, kinase genes mainly active in immunological/hemato-
logical tissues were identified (63.3% activity in these tissues vs, 11.3-
16.7% in other tissue groups). Other identified example groups of
kinase genes include ‘‘neuronal, ’’non-epithelial’’, ‘‘epithelial’’ and
‘‘generally’’ active (see Table 1 for average activity levels and
Figure 1). Example kinases for the identified groups were AURKA
[21] for proliferation kinases, MATK [22] for immunological/
hematological kinases, PRKCE [23] for neuronal kinases, PTK2 [24]
for non-epithelial kinases, ERBB2 [25] for epithelial kinases and
RPS6KC1 [26] for general kinases. Measured mRNA expression
levels for these example kinase genes are shown in Figure S2. Table
S3 provides transcriptional activity information for all 459 kinases
across 99 tissue types allowing further study of both individual
kinase genes as well as healthy versus cancer comparisons between
tens of tissue-malignancy pairs.
Co-expression network analysis to determine the
functional context of kinase genes
We then performed an analysis of the putative functional
context associations for each kinase gene by defining their gene co-
expression networks. This analysis was done with mRNA
expression levels of kinases genes, not with the binarized data.
The network of co-expressed genes around each kinase gene was
calculated in a consecutive fashion, including up to a maximum of
five co-expression links (see methods) originating from the kinase
gene. Altogether, a total of 70.9 million correlations were
processed. We then searched for statistically significant relative
enrichments of Gene Ontology biological processes (GO-BP) [27]
in the co-expression network around each kinase gene, resulting in
putative functional context associations for each kinase gene
(Figure 2, Figure S4). Complete information of all associations to
each GO-BP class is given in the Table S4. Data for Figure 2A are
given in the Table S5. Pearson correlation coefficients between the
kinase genes and specific marker genes of well known biological
functions were calculated to further validate the suggested
functional associations of the kinase genes (Figure 2B). Expression
of MKI67 [28] and PCNA [29] genes, two well-established cell
proliferation markers, showed the highest correlations with kinases
strongly associating to mitosis and cell cycle. Similarly, LDHC
(germ-cell specific marker) [30], PTPRC (marker for hematopoi-
esis) [31], VCAM1 (endothelial/vascular cell marker) [32], KRT19
(epithelial marker) [33], MAG (neuronal cell marker) [34] and
CAV3 (myocyte marker) [35] correlated with the kinase genes with
corresponding functional associations.
We then elucidated the functional context associations of the
kinase gene groups identified from the transcriptional activity data
(Figure 1A, Table 1). Almost all kinase genes of the ‘‘proliferation’’
group (Figure 3) associated with DNA repair, cell cycle control,
mitotic chromosome handling, chromatin handling and regulation
of cell growth. These associations arise since the kinases were
transcriptionally active in rapidly proliferating tissues (cancers and
hematological tissues). These include the well-known mitotic
kinase genes (AURKA [36], BUB1 [37], PLK1 [38], TTK [39],
CDC2 [40], PBK [41], BUB1B [42], PLK4 [43], NEK2 [44],
CHEK1 [45], AURKB [46], CDK2 [46]), but also several novel ones
(MASTL, MELK, DYRK2, PRKDC) which are not yet experimen-
tally proven to be mitosis and/or cell cycle related. Similarly
analysis of the ‘‘Nervous’’ kinase genes (Figure 3) gave associations
with synaptic function, nervous system development & function.
Kinase genes from ‘‘immunological’’ group had more diverse
associations but included immune response, B-cell, myeloid cell
and T-cell proliferation & differentiation, response to stimulus and
RNA splicing (possibly related to heavy splicing activity of
immunoglobulin genes). ‘‘Non-epithelial’’ kinase genes were
associated with cytoskeleton organization, cell adhesion, mesoder-
mal and epidermal development. Dominant functional context of
‘‘Epithelial’’ kinase genes was epidermal development. ‘‘General’’
kinase genes had associations with many diverse biological
processes, suggesting a group of kinases with many different
functions.
Gains and losses of kinase activity in prostate and lung
cancers
After establishing the overall validity of interpretation of
transcriptional activity levels (Figure 1A–B) and functional context
associations (Figure 2A–B, Figure 3A–B) we studied which kinase
genes gained and which lost transcriptional activity in malignant
tissues as compared to the corresponding normal tissues (Figure 4,
Figure 5) and how these cancer-related changes compared with
the potential biological processes discovered for these genes.
Comparing the transcriptional activity profile of healthy prostate
with prostate cancer (PRCa) reveal that 37 kinase genes had
gained and 31 lost transcriptional activity in malignant prostate
cancers (Figure 4). This represents 14,8% of all the kinases
indicating that for most kinases prostate cancers and normal
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tissues are rather similar, as reflected in the kinome clustering data
(Figure 1). The kinase genes gaining activity in prostate cancer
were associated with DNA replication, cell cycle control, mitotic
chromosome handling and regulation of cell growth. Among these
genes BUB1 [37] is the best known to be mitosis related, but also
MASTL had strong associations with mitosis and cell cycle. It does
not have an experimentally proven role in mitosis except of one
observation where it was recognized as part of the mitotic gene
signature predicting poor survival in luminal breast cancer [47].
CHEK1, a kinase with a key role in maintaining genome integrity
[48], and MELK, a kinase known to associate with embryogenesis
and the undifferentiated state of cells [49], both lost their
transcriptional activity in prostate cancer despite of being strongly
associated with mitosis in the general gene co-expression network
analysis. This indicates potentially important functions for these
genes in prostate cancer. For example, the loss of CHEK1
transcriptional activity may link to the recently reviewed deficient
DNA repair process in PRCa [50]. The most prominent functional
associations of kinase genes whose expression was lost in prostate
cancer were linked to cytoskeletal organization, cell adhesion and
mesodermal development (Figure 4). Among these genes DDR2
[51] has previously shown to mediate contact inhibition of cancer
cells.
Among the 37 kinase genes gaining activity in PRCa in
comparison to healthy prostate there were 22 kinase genes
(MASTL, CCRK, NEK6, MAP3K13, DCLK1, CSNK1G3, ATR,
SBK1, TESK2, BRSK2, FGFRL1, VRK1, PRKCZ, PKN2, LMTK3,
CDK3, NRBP2, MAP4K3, MARK1, MARK4, TSSK4, ENSG
00000121388) without previous association to PRCa based on
the Pubgene [52]. The remaining 15 kinase genes (NEK3, STK39,
LIMK1, TRIB3, STK36, BUB1, RIPK2,MARK2,MAP3K5, PRKCD,
ENSG00000143674, MAP2K6, ALK, PDIK1L and ICK) had 3–17
co-occurrences with PRCa in PubMed.
A similar comparison between healthy lung and lung adeno-
carcinoma revealed that 55 kinase genes gained and 51 lost
transcriptional activity in the cancer, corresponding to a total of
23,1% of the studied kinase genes (Figure 5). This is reflected in
the large difference of the transcriptionally active kinome between
the healthy lung and lung adenocarcinoma (Figure 1B). Among
the 55 kinase genes gaining transcriptional activity, the functional
association to cell cycle control was found to be even more
prominent than in PRCa (Figure 4). EGFR was found to be
transcriptionally active in very many epidermal tissues, including
healthy and malignant lung tissues, which is as expected from one
of the most influential epithelial growth factor receptors. ALK is
also among the kinases that gain activity in lung adenocarcinomas,
lung carcinoid tumors and squamous cell lung carcinomas in
comparison to healthy lung. Its main functional associations relate
to DNA repair, DNA replication, mitotic chromosome handling
and mRNA splicing.
Exploration of poorly known kinases genes for their
transcriptional activity and functional context
associations
Transcriptional activity levels and functional context associa-
tions make it possible to explore and annotate the entire kinome,
and hence provide potential starting points to predict context-
specific functions of relatively poorly understood kinase genes. For
example, VRK1 was found to be transcriptionally active in both
healthy and malignant hematological tissues (Figure 6A). Previ-
ously it has found to differentiate Imatinib responders among
CML patients [53], but otherwise its role in hematological tissues
is not well known. It is also active in almost all tumors of
connective and muscular system (sarcomas, head and neck and
melanoma), with a previously shown role in head and neck
squamous cell carcinomas [54]. The most prominent difference in
transcriptional activity between healthy and malignant tissues for
VRK was seen in gynecological cancers, including breast, cervical,
ovarian and uterine cancers. VRK1 had strong functional context
associations to cell cycle control, mitotic chromosome handling
and chromatin handling biological processes and it has recently
been associated with mitosis and performs similar functions as
AURKA [54,55,56] and its role in cell proliferation has been shown
with siRNA experiments [57] (Figure 6B). Previously, VRK1 had
not been associated with all of these cancers even though it is part
Table 1. Average percentage of tissues of each distinct tissue group where kinase genes of the identified groups are
transcriptionally active.
Kinase group Healthy
Healthy
(neuronal)
Healthy
(muscular) Mixed
Solid
cancer
Solid cancer
(epithelial)
Solid cancer
(non-epithelial) Immunological
Proliferation 20.8% 12.5% 6.3% 44.2% 88.7% 87.8% 87.1% 65.8%
Immunological 14.5% 12.5% 13.5% 12.6% 16.7% 16.7% 11.3% 63.3%
Neuronal 26.2% 55.4% 25.6% 8.6% 5.4% 8.5% 9.7% 5.5%
Non-epithelial 32.3% 29.0% 28.6% 28.3% 32.2% 19.5% 52.4% 12.2%
General 78.2% 70.0% 100% 75.0% 75.5% 84.0% 68.7% 52.6%
Epithelial 36.9% 10.4% 12.5% 57.1% 37.7% 58.8% 9.4% 18.9%
doi:10.1371/journal.pone.0015068.t001
Figure 1. A) Kinase transcriptional activity over 44 healthy and 55 malignant tissues. The number of samples per tissue is given in
parentheses. The x-axis contains 459 kinase genes. Black indicates transcriptional activity of the kinase in the tissue. The figure has been clustered in
both dimensions (binary distance measure with complete linkage). Several tissue groups can be identified (marked as color bars on the right side of
the image). Correspondingly several groups of kinases can be identified having a distinctly different activity profile in tissue groups (colored vertical
bars, with kinase gene names of the identified groups shown below). B) Tree of tissues as defined their by transcriptionally active kinome
(same as on the left side of image in panel A). The four main groups of tissues are mainly solid healthy tissues (92.6%), immunological &
hematological (94.7%), solid cancer tissues (94.7%) and a mixed one. Within these groups there are some more specific clusters like neuronal and
muscular on the healthy side and non-epithelial and epithelial on the cancer side. Epithelial cancers also show visible tendency to cluster to adeno
and squamous groups according to their transcriptionally active kinome.
doi:10.1371/journal.pone.0015068.g001
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of the signature depicting poor survival of luminal breast cancer
patients [47].
An almost completely unknown kinase gene from an open
reading frame of chromosome 21 was C21orf7 (also known as
TAK1L), which we decided to study in more detail. C21orf7 was
found to be transcriptionally active in immunological tissues,
especially in several lymphomas and in mesenchymal- and adult
stem cells (Figure 6A). This corresponds to what is previously
known about this gene, an association to differentiating stem cells
[58] and strong expression in peripheral leukocytes [59].
Additionally, it was found to be transcriptionally active in
adrenocortical-, renal- and hepatocellular carcinomas. The
functional context associations link this gene firmly in the B- and
T-cell signalling and differentiation as well as to immunoresponse,
in line with a prominent transcriptional activity in immunological
tissues (Figure 6D). The functional annotations also link this gene
with signal transduction, metabolism, mesodermal development
and cytoskeleton organization, perhaps elucidating some of the
biological processes to which the gene associates in stem cells [58].
Another relatively unknown kinase gene IGFN1 (ENSG
00000163395) is previously known only to down-regulate protein
synthesis during the denervation of skeletal muscle as well as to
provide structural support for the skeletal muscle sarcomere
[60,61]. Our analysis revealed it to be transcriptionally active in
various healthy tissues like pancreas, testis, striated muscle, ovary
and uterus. Additionally, lung carcinoid tumor had transcriptional
activity without activity in the most corresponding healthy tissue.
Functional context associations reveal this kinase gene to be
mainly related to muscle contraction, muscle and heart develop-
ment, epidermal development, translation, skeletal cytoskeleton
organization and cellular calcium ion homeostasis (Table S3, S4
and S5). Interestingly, there are previous indications that
neuroendocrine carcinomas have a higher tendency to differen-
tiate towards skeletal muscle [62,63], perhaps explaining the
observed transcriptional patterns in the lung carcinoid tumor.
Discussion
We assessed the transcriptional activity levels of human kinase
genes across 99 tissues and tumor types bioinformatically, and
were able to show how the transcriptionally active kinomes are
distinct from one tissue type to another and between cancer and
normal tissues. While there are hundreds of studies on the
expression of individual kinase genes or proteins in specific sample
types, this represents to our knowledge the first systematic attempt
to compare mRNA expression levels across all kinases and across
all major tissue and tumor types with similar methodology. Based
on the definition of the transcriptionally active kinome, we
observed five broad categories of tissue types, including hemato-
logical-immunological, other normal tissues, as well as epithelial
and non-epithelial cancers (Figure 1B). Epithelial cancers were
further divided into squamous- and adenocarcinomas. These
observations characterize expression activities of the kinase genes
systematically across the full spectrum of normal and malignant
diseases. The results suggest that the transcriptional activities of
kinases can cluster tissue types in a biologically meaningful way,
despite the fact that the activity of kinases is strongly regulated by
post-translational events.
We also estimated the biological context of kinase genes from
the analysis of their transcriptional co-expression environment
[64,65]. Biological processes that were linked to specific actively
transcribed kinases included immune response, neuronal, cell
proliferation, mRNA translation and muscle function. The group
of ‘‘proliferation’’ associated kinase genes was linked to cell cycle
control, mitotic chromosome handling, DNA replication, DNA
repair and regulation of cell growth whereas example kinase genes
associating to these processes were well known mitosis related
kinases AURKA [21], BUB1 [37] and TTK [66]. ‘‘Neuronal’’ kinase
genes were associated to GO-terms nervous system development &
differentiation and synaptic function whereas example kinase
genes associating to these processes were PRKCE [23] and EPHA4
[67], both known for nervous system related functions. Functional
context associations arising from gene co-expression analysis do
not suggest new GO annotations for genes. However, they reveal
the biological processes of the poorly known kinase genes based on
the known functions of other genes that are coordinately expressed
with the gene of interest. The method of co-expression analysis
used here finds systematic functional associations that are
consistent and shared across the different tissue and tumor types.
There could be additional highly tissue-specific functions that
could be identified using co-expression analysis within a specific
tissue/tumor type. Overall, classification of kinases based on
transcriptional activity and functional associations complements
the established structural homology classification by Manning et
al.[68]. Importantly, there is very little similarity based on kinome
protein structure and the expression patterns of the kinases
indicating that knowing these two properties of kinases is
important for understanding the biological and therapeutic
implications of this group of genes.
For example, a mitosis related kinase gene VRK1 was found to
be active in many hematological tissues as well as in the many
tumors of connective and muscular tissues (sarcomas, head & neck
and melanoma) and in most gynecological cancers (uterine,
ovarian and breast cancers) (Figure 6A–B). Functional associations
reflected what is already known about VRK1, like its association to
cell cycle control and mitosis with similar functions as AURKA
[54,55,56]. It has also been established that VRK1 and p53 form
an autoregulatory loop where active wt-p53 inhibits VRK1 but
altered p53 is unable to do so [71].
C21orf7, also known as TAK1L and TGF-beta activated kinase
like gene is a rather poorly known kinase gene [58–59]. Its name
originates from sequence homology with TAK1, which belongs to
the nuclear hormone receptor family. However, there is no
information regarding functional similarities between TAK1L and
TAK1. Analysis of its transcriptional activity confirmed TAK1L to
be a hematological- and stem cell-specific gene with gene co-
expression analysis associations indicating potential involvement in
T- and B-cell differentiation, immune response as well as
Figure 2. A) Functional associations of human kinase-encoding genes. The x-axis contains 459 kinase genes and the y-axis contains GO-BP
classes. For the sake of clarity only those biological processes (GO-BP) enriched in the co-expression environment of at least 15 kinases are shown
(301). Detailed information of all GO-BP class associations of the kinase genes are given in the Supplementary tables. The x-axis has been clustered
with binary distance measure with complete linkage. The y-axis has been clustered in terms of semantic similarity of the GO-BP classes. The
predominant biological interpretations of each cluster are given on the right side of the image. The analysis of the co-expression space made it
possible to elucidate in what kind of biological processes kinase genes are expressed. B) Pearson correlation coefficients of functional and
tissue specific marker genes with the expression levels of each kinase gene. Below the figure are listed the gene names in two groups
kinase genes. The group on the left is associated with cell cycle and mitotic chromosome handling and has elevated correlation to MKI67 and PCNA.
The group on the right is associated to epidermal development and has elevated correlation to KRT19.
doi:10.1371/journal.pone.0015068.g002
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homeostasis and mesodermal development (Figure 6C-D). TAK1L
has been previously reported to be one of the genes overexpressed
in mesenchymal stems cells during osteogenic differentiation [58]
and having highest expression in peripheral leukocytes [59].
Interestingly, we observed transcriptional activity in some solid
tumors, such as uterine sarcoma, renal-, adrenocortical- and
hepatocellular carcinomas, with little or no expression in the
corresponding normal control tissues. This could reflect a role for
this gene in tumor progression, perhaps via de-differentiation and
tumor stem cell involvement.
Analysis of IFGN1 revealed known functional roles for this gene,
including relation to muscle development and contraction as well
as protein translation [60,61]. However, the co-expression
environment analysis gave additional information that this kinase
gene may also play a role in epidermal development, keratiniza-
tion in particular. Systematic analysis of its transcriptional activity
also revealed that it is active in various other healthy tissues like
pancreas, testis, ovary, uterus and striated muscle as well with a
potential role in carcinomas with neuroendocrine differentiation
like in lung carcinoid tumor.
As this study provides information on the systematic transcrip-
tional activity levels of all kinases in all tissues, as well as functional
associations of each kinase, we have released all the data on tissue
and disease links as well as predicted functional roles of the kinases
in the supplementary data to support the utilization of these
insights by the scientific community interested in specific kinases
(Table S3, S4 and S5).
The transcriptional levels of the kinase genes as well as their
predicted functional associations are likely to be essential when
exploring the role of kinases in disease and when defining
indications where kinase activity in a disease tissue is higher than
that in any normal tissue. This could provide a basis for specific
therapeutic targeting.
The kinase genes gaining transcriptional activity in PRCa when
compared to healthy prostate were associated with cell cycle
control, mitotic chromosome handling and DNA replication; while
kinase genes were losing transcriptional activity in PRCa were
associated with cytoskeleton organization, cell adhesion, meso-
and epidermal development. Altogether 22 kinase genes previously
not associated to PRCa were shown to be transriptionally active in
PRCa but not in healthy prostate. These kinase genes include
CCRK which is established cell cycle related kinase [69], MASTL
which is a relatively unknown kinase gene associated with mitosis
through co-expression analysis and NEK6 which is also an
established mitosis related kinase [70]. Changes between healthy
lung and lung adenocarcinoma (Figure 5) were more prominent
than in the case of prostate suggesting that lung cancer progression
involves a deeper deregulation of its kinome transcriptome than in
prostate cancer (B).
Also, systematic analysis of kinase transcriptional activities
across all healthy tissues could help to prioritize for further study
those kinases, whose activation is most disease specific, and hence
whose inhibition would theoretically cause fewer side effects. For
example, EGFR was found to be transcriptionally active in healthy
skin (hair follicles), adrenal gland, bladder, lung, esophagus and
colorectal, bronchus, kidney, mesenchymal and adult stem cells in
addition to CNS and some gynecological tissues. Currently
identified side effects of the various anti-EGFR therapies include
skin rash due to the changes in keratinocyte and hair follicle
maturation [72], interstitial lung disease and other respiratory
problems [72,73]. Gastrointestinal toxicity [73] and hypomagne-
semia have been reported due to the EGFR blockade in kidneys
[72]. These correspond well with the observed healthy tissues
having a transcriptionally active EGFR. ERBB2/HER-2 was found
to be transcriptionally active in various healthy tissues, including
heart, colorectal, esophagus, kidney, bladder, bronchus and lung.
The most common adverse effects of anti-ERBB2 therapy are
cardiotoxicity and intestinal problems like diarrhea [73] with some
indications of respiratory problems [74,75]. Obviously, there are
many reasons for side effects in the human body, and these cannot
be reduced simply to transcriptional levels of the genes.
Nevertheless, these examples give some indication of the potential
of this transcriptomics approach to predict normal tissue effects of
kinase inhibitors.
Results presented in this paper rely to a large extent on the
GeneSapiens database [18] (www.genesapiens.org), which pro-
vides integrated gene expression data and gene co-expression
environment analysis [18,76]. Transcriptional activity levels of
kinases were estimated by taking advantage of the genome-wide
data coverage of GeneSapiens to determine the overall body-wide
background levels for the transcriptional activity of each kinase
gene. This is a distinct advantage of the present method, which
takes into account the transcriptional variability of genes across the
body, not just between e.g. a cancer of one organ and the
corresponding normal tissue as is typically done in biomedical
studies. Systematic use of integrated gene expression data, such as
GeneSapiens, allows the definition of universal cutoff points for
transcriptional activity across all tissue types, which then makes it
possible to identify active gene expression regulation in a tissue
even when the relative expression increase between tissues to be
compared is only modest. Human tissues have distinct transcrip-
tionally active kinomes with functional associations supporting the
results. Most of the known kinases were active in previously
reported tissue types and had expected functional associations.
The present study was designed for systematic global character-
ization of kinase gene transcriptional activity and functional
context associations, therefore it is not optimal to directly pinpoint
the most obvious therapeutic targets of each cancer type.
Expression levels were binarized (on/off) for the global
comparisons across all tissue and tumor types in order to facilitate
computations, data interpretation and to reduce noise [19,20].
The co-expression environment was analyzed from the actual
measured mRNA expression levels, not from binarized data. Co-
expression analysis using Pearson correlations has been previously
shown to be a useful technique to facilitate understanding of gene
functions [64,65,77]. Our present analysis focused on generic co-
expression associations. An interesting future aspect for co-
expression environment analysis is to define the gene co-expression
Figure 3. Functional context associations of example kinase gene groups (Figure 1). A) The y-axis contains GO-biological processes in the
same order as in Figure 2. ‘‘Immunological’’ kinase genes (marked with red) associate mainly to B-cell, T-cell and myeloid cell proliferation &
differentiation as well as to immune response. ‘‘Neuronal’’ kinase genes (marked with grey) associate strongly to neuronal functions. ‘‘Proliferation’’
kinase genes (marked with orange) associate very strongly to cell cycle control, mitotic chromosome handling, DNA replication, DNA repair and
regulation of cell growth. ‘‘Non-epithelial’’ kinase genes (marked with yellow) associate most to cell adhesion, cytoskelton organization, epidermal
development and mesodermal development. Functional associations of kinase genes active in most of 99 analyzed tissues (‘‘General’’, marked with
blue) seems to cover almost all processes present in the analysis with marginally more in RNA splicing, muscle contraction and myeloid cell
proliferation & differentiation. As assumed, ‘‘Epithelial’’ kinase genes associate strongly to epidermal development. B) The average frequency of
kinase genes per group associating to each functional category.
doi:10.1371/journal.pone.0015068.g003
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network and subsequent functional associations in a tissue-specific
manner. This would provide more specific functional associations
and allow more detailed understanding of functions related to
chances in transcriptionally active kinome between e.g. healthy
and malignant counterparts. Obviously, any bioinformatic esti-
mation of the transcriptomic activity is highly dependent on the
thresholds applied, and laboratory validation of the results is
needed. Original non-binarized gene expression data of all
presented kinases can readily be explored at www.genesapiens.
org. Example figures of bodywide expression levels of
specific kinases, including AURKA, PTK2, MATK, ERBB2, PRKCE
and RPS6KC1, which were discussed above, are shown in
Figure S2.
In summary, we have shown how the definition of transcrip-
tional activity of kinases and their co-expression environment will
help identify potential functional roles of the kinases in health and
disease. To our knowledge this is first systematic characterization
of the human kinome across major human tissue and cancer types
at the transcriptional level, together with functional associations
with other transcribed genes. Major tissue classes having a distinct
transcriptionally active kinome were found to be 1) healthy tissues,
with subgroups of neuronal and muscle tissues, 2) immunological/
Figure 4. Gain and loss of transcriptional activity between healthy prostate and prostate cancer. On the x-axis (clustered with binary
distance and Ward linkage) are 68 kinases whose transcriptional activity is either gained (green color) or lost (red color) in prostate cancer when
compared to healthy prostate. On the y-axis are functional context associations of the kinases in the same semantically defined order as in Figure 2.
This analysis allows identification of kinases whose transcription is elevated to active level or kinases whose biologically active level is most likely lost
as well as the functional context to which the kinases are associated. Some notable changes in the kinome transcriptome include the losses of
transcriptional activity of BMX, NRK, ILK, DDR2, AXL and RYK which all associate to processes like cytoskeleton organization, cell adhesion, meso- and
epidermal development. Similarly, there is a group of kinases with gained transcriptional activity (MASTL, VRK1, BUB1, ALK, PDIK1L, ATR, LIMK1, TRIB3,
CSNK1G3) associating to cell cycle control, mitotic chromosome handling, DNA replication and regulation of cell growth.
doi:10.1371/journal.pone.0015068.g004
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hematological tissues, 3) solid tumors with subgroups of epithelial
and non-epithelial tumors and 4) a mixed class. The most readily
indentified functional associations for a group of kinases included
proliferation related processes, neuronal process, muscle tissue
processes, DNA replication and repair, transcription and transla-
tion regulation, immunological response and development pro-
cesses of various tissue types. This ‘‘body-wide’’ approach for
transcriptomic analysis of gene activity and functional context
could readily be expanded to other biologically and medically
interesting gene sets.
Methods
Definition of kinase genes
Human protein kinase genes were selected from the Panther
database version 6.1 [78,79]. This set of protein kinases (529) was
further filtered in terms of expression data availability from
GeneSapiens database [18] for a total of 459 protein kinases
(Table S1). Kinase genes had a minimum of 2583 common values
with each other over 5681 samples covering 99 distinct healthy
and pathological tissues (Table S2).
GeneSapiens database
Expression data were fetched from the GeneSapiens database
[18] with additional data from GEO studies GSE15459,
GSE12452, GSE9843, GSE10927, GSE8167, GSE9576,
GSE12102, GSE13314 and GSE9844 to extend the tissue
coverage of the GeneSapiens data. GeneSapiens contains
integrated gene expression data from 9783 samples covering 175
types of healthy and pathological human tissues. Data in
GeneSapiens have been integrated and normalized as described
by Kilpinen et al. [18] and Autio et al. [76]. Additional data were
integrated by using MAS5 and EQ normalization as previously
described [18,76] and AGC normalization [18,76] by using gene
and array specific correction factors used in GeneSapiens database
construction [18]. This process rendered the new data directly
comparable with existing GeneSapiens data.
Figure 5. Gain and loss of transcriptional activity between healthy lung and lung adenocarcinoma. On the x-axis (clustered with binary
distance and Ward linkage) are 106 kinases whose transcriptional activity is either gained (green color) or lost (red color) in lung adenocarcinoma
when compared to healthy lung. On the y-axis are functional context associations of the kinases in the same semantically defined order as in the
figure 2. This analysis allows identification of kinases whose transcription is elevated to active level or kinases whose biologically active level is most
likely lost as well as the functional context to which the kinase genes are associated. Some notable changes in the kinome transcription include a
major gain of kinases associating to DNA replication, cell cycle control, mitotic chromosome handling and regulation of cell growth.
doi:10.1371/journal.pone.0015068.g005
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Definition of active transcription
Expression levels of each gene were analyzed to define tissues
where it is actively transcribed. In other words, each gene was
tested in each tissue to see whether its expression level was above
the defined background noise levels. The gene was defined to be
transcriptionally active in a tissue if its median expression in the
tissue was more than the predefined background expression level
(Figure S1). Background expression level for each gene was
calculated as follows: expression level entropy of sample
annotation class labels was calculated in a sliding window (with
width of 5% of maximum expression value) from zero expression
to maximum level. The midpoint of the window with the highest
entropy level was recorded. The variance of the data below this
midpoint was calculated, and 2 x standard deviation was added to
the midpoint to reach the background cutoff level. 2 x SD results
in 95% coverage of the assumed normal distribution of the
background expression the gene. Thus, every gene defined as
transcriptionally active has a p-value # 0.025 against the null
hypothesis that it derives from the background expression (which
should be not be defined as transcriptionally active). Selection of a
higher threshold leads to more stringent conditions of defining
genes as transcriptonally active, which eventually degrades the
resolution of the digitalized expression levels’ ability to separate
tissues. 2 x SD was found to be reasonable compromise between
reliability and sensitivity.
Co-expression network analysis
To define functional context associations of kinase genes we
calculated a genomic co-expression network across 5712 samples
(31 samples included here were omitted from transcriptional
activity level calculations due to the incomplete annotation) for
each of the kinase genes. The genes (n = 11 906) were chosen so
that all genes had enough values in common to calculate
correlation coefficient. We then calculated Pearson correlation
coefficients between all genes. The correlation network around
each of the kinases was then analyzed to identify prominent genes
related to the kinases. This analysis was based on random walking
along defined correlation links (edges) between genes (nodes). For
each kinase, we performed 500 random walks, each 5 steps long,
originating from the kinase in question, collecting all genes (nodes)
encountered. Steps were not allowed to go directly backwards and
each step was allowed to randomly choose only from valid
correlation links. The validity of correlation links was defined on a
gene-by-gene basis as follows. Valid links for each gene were those
having a correlation value in the top 99.9 percentile of all
correlations for that gene. This was done since the variability of
correlation coefficients hindered efforts to define a single
universally applicable cutoff level. Thus, for each kinase we
identified a frequency distribution of genes that were encountered
in the near vicinity at its co-expression network. Overall, this co-
expression network analysis method took into account the
topology of co-expression network and the highly dynamic range
of correlation coefficients between the genes. Genes identified in
the co-expression network of each kinase were subsequently
analyzed in terms of Gene Ontology biological process (GP-BP)
class enrichments.
Functional context associations of kinase genes
Genes in the co-expression network around each kinase were
analyzed for significant enrichments of GO-BP classes by using R
library GOSim [80]. All enrichments with p-value ,0.01 were
accepted. This analysis resulted in a list of significantly enriched
GO-BP classes in the co-expression network around the kinase, thus
associating each kinase with GO-BP classes. For visualization, only
those GO-BP classes associating with at least 15 kinase genes were
selected (301 GP-BP classes). The order of GO-GP classes (y-axis) in
Figures 2–5 is defined by clustering GO-BP classes by using
semantic similarity between the GO-BP classes over the entire
diacyclic graph (DAG) of GO-BP ontology (GOSim library [80],
Lin semantic similarity measure [81] and Ward linkage method).
Supporting Information
Figure S1 Schematics of defining transcriptionally
active level of gene (ERBB2 shown as an example). A–B
entropy of tissue type distribution is calculated in a sliding window
(window width 5% of the maximum of the gene) and expression
level with maximum entropy is identified C) standard deviation of
data points below the identified level is calculated D) Background
level is defined to be 2 x standard deviation + the expression level
with maximum entropy. The gene is defined to be transcriptonally
active in a tissue if the median of tissue is above the background
activity level.
(EPS)
Figure S2 Bodywide expression profiles of six example
kinases from GeneSapiens. Green boxes are healthy tissues
while red boxes are malignant tissues. Median expression level of
the gene in question is indicated by black line, boxes extend from
25th to 75th percentiles, while whiskers extend to the 1.5*IQR.
Data points beyond are shown as individual points. A) AURKA
shows generally increased expression in cancers and in some
proliferation active healthy tissues B) PTK2 is mainly expressed in
mesenchymal and neuronal tissues highlighting the non-epithelial
classification of the kinase gene C) MATK is expressed in
immunological/hematological tissues D) ERBB2 is expressed
mainly in epithelial tissues E) PRKCE is relatively specifically
expressed in both central- and peripheral nervous system F)
RPS6KC1 is expressed in various healthy and malignant tissues.
(EPS)
Figure 6. Transcriptional activity level across 44 healthy and 55 malignant tissues and functional context associations of individual
kinases. A) Transcriptional activity levels of VRK1. Vertical ordering of tissues is based on the anatomical system from which the tissue originates
(colored bar on the left). The left column shows transcriptional activity levels across 44 healthy tissues (white = transcriptionally non-active, black =
transcriptionally active). The right side shows transcriptional activity levels across 55 malignant tissues. B) Functional context associations of the VRK1.
Barplot shows the fraction of GO-BP classes of each functional category being associated to the gene through its co-expression environment.
According to the analysis VRK1 seems to be in generally transcriptionally active in both healthy and malignant hematological tissues. It is also active
in almost all tumors of connectivity and muscular system (sarcomas, head and neck and melanoma). The most prominent difference between healthy
and malignant tissues is in female specific tissues as the gene is transcriptionally active in all histological subtypes of breast, cervical, ovarian and
uterine cancers, but not in any of the corresponding healthy tissues. VRK1 has strong functional context associations to cell cycle control, mitotic
chromosome handling and chromatin handling. C) C21orf7 is transciptionally active in immunological tissues, especially in several lymphomas. It is
also active in mesenchymal and adult stem cells. Additionally, there is a possible ectopic expression of this otherwise lymphoid and stem cell specific
gene in few distinct carcinomas. D) The functional context associations lands gene firmly to the B- and T-cell signaling and differentiation as well as to
immuno response, response to stimulus and homeostasis related processes.
doi:10.1371/journal.pone.0015068.g006
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Figure S3 Zoomable eps version of the Figure 1 A)
Kinase transcriptional activity over 44 healthy and 55
malignant tissues. The number of samples per tissue is given in
parentheses. Black indicates transcriptional activity of the kinase in
the tissue. Figure has been clustered in both dimensions (binary
distance measure with complete linkage). Several tissue groups can
be identified (marked as color bars on the right side of the image).
Correspondingly several groups of kinases can be identified having
distinctly different activity profile in tissue groups (colored vertical
bars). B) Tree of tissues as defined by transcriptionally active
kinome (same as on the left side of image in panel A). Four main
groups of tissues are mainly solid healthy tissues (92.6%),
immunological & hematological (94.7%), solid cancer tissues
(94.7%) and mixed one. Within these groups there are some more
specific clusters like neuronal and muscular in healthy side and
non-epithelial and epithelial on the cancer side. Epithelial cancers
also show visible tendency to cluster to adeno and squamous
groups according to their transcriptionally active kinome.
(EPS)
Figure S4 Zoomable eps version of the Figure 2 A)
Functional associations of human kinase-encoding
genes. The x-axis contains 459 kinase genes and the y-axis
contains GO-BP prosesses. For the sake of clarity only biological
processes (GO-BP) enriched in the coexpression environment of at
least 15 kinases are shown (301). X-axis has been clustered with
binary distance measure with complete linkage. Y-axis has been
clustered in terms of semantic similarity of the GO-BP classes. The
predominant biological interpretations of each cluster are given on
the right side of the image. The analysis of the coexpression space
made it possible to elucidate in what kind of biological processes
kinase genes are expressed. B) Pearson correlation coefficients of
functional and tissue specific marker genes with the expression
levels of each kinase.
(EPS)
Table S1
(TXT)
Table S2
(TXT)
Table S3
(TXT)
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(TXT)
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